Pulmonary Fibrosis

Pulmonary fibrosis (PF) is a chronic and progressive lung disease characterized by the scarring and thickening of lung tissue. This scarring, also known as fibrosis, makes the lungs stiff and reduces their ability to expand and contract properly. As the fibrosis worsens over time, it becomes increasingly difficult for oxygen to pass from the lungs into the bloodstream, leading to shortness of breath.   The causes of PF are diverse and often remain unknown (idiopathic pulmonary fibrosis). Known causes and associated conditions include exposure to certain environmental pollutants, some medications, radiation therapy, and connective tissue diseases like rheumatoid arthritis and scleroderma. Symptoms typically develop gradually and include shortness of breath (initially during exertion and later at rest), a dry, hacking cough, fatigue, and unexplained weight loss.  
Unfortunately, there is currently no cure for pulmonary fibrosis, and the scarring is irreversible.
However, various treatments are available to help manage symptoms, slow down the progression of the disease, and improve quality of life. These include medications, pulmonary rehabilitation to improve exercise tolerance and breathing techniques, and in some cases, lung transplantation. Early diagnosis and appropriate management are crucial for individuals living with pulmonary fibrosis

Research Progress

The Open Science Institute’s Pulmonary research project has progressed now to the Second stage of publication. Our goal is to raise $1 Million to to curate, analyze and publish the data which can lead to revolutionary research outcome. Please support this initiative.

Systems Architecture

The Systems Architecture of pulmonary fibrosis is published as a Web-based tool open to public. Click below to interact with the systems architecture

Publication

A peer-reviewed publication from the Pulmonary fibrosis Initiative will be released soon to benefit the public by revealing powerful natural ingredients to treat of pulmonary fibrosis—support this initiative to advance scientific discovery and deliver real solutions.

In silico Modeling

In this phase, the pulmonary fibrosis Initiative will conduct in silico modeling to identify and test the efficacy of natural ingredients on pulmonary fibrosis. This phase is yet to begin.

Combination Screening

Patents

The Open Science Institute® through its Pulmonary fibrosis research initiative is moving towards getting patents for a revolutionary natural ingredients that affects lung health.

Licensing and Manufacturing

The pulmonary fibrosis Initiative plans to discover, develop, license and manufacture a nutraceutical product which supports treatment of many diseases. Support our mission to bring this innovation to those who need it most. Please support this Phase by donating to the pulmonary fibrosis research initiative